SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-321821
Filing Date
2013-08-06
Accepted
2013-08-06 17:01:01
Documents
12
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d559908d10q.htm 10-Q 754554
2 EX-10.5 d559908dex105.htm EX-10.5 161606
3 EX-10.6 d559908dex106.htm EX-10.6 166233
4 EX-31.1 d559908dex311.htm EX-31.1 9289
5 EX-31.2 d559908dex312.htm EX-31.2 9321
6 EX-32.1 d559908dex321.htm EX-32.1 5247
  Complete submission text file 0001193125-13-321821.txt   7966208

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT sgnt-20130630.xml EX-101.INS 758706
8 XBRL TAXONOMY EXTENSION SCHEMA sgnt-20130630.xsd EX-101.SCH 49083
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgnt-20130630_cal.xml EX-101.CAL 83332
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgnt-20130630_def.xml EX-101.DEF 322990
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgnt-20130630_lab.xml EX-101.LAB 362572
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgnt-20130630_pre.xml EX-101.PRE 384984
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35144 | Film No.: 131014272
SIC: 2834 Pharmaceutical Preparations